Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Moelis & Company (MC.N)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2021-08-20	60.57	62.00	Buy
2021-10-01	64.83	70.00	Buy
2021-10-27	68.56	74.00	Buy
2021-11-04	76.12	85.00	Buy
2022-01-04	62.65	73.00	Buy
2022-02-09	58.47	69.00	Buy
2022-03-31	46.95	60.00	Buy
2022-04-27	44.88	54.00	Buy
2022-07-06	39.99	40.00	Neutral
2022-07-27	43.93	43.00	Neutral
2022-09-22	37.04	35.00	Sell
2022-11-02	43.01	32.00	Sell
2023-01-09	42.84	30.00	Sell
2023-04-11	40.23	27.00	Sell
2023-07-10	45.87	32.00	Sell
2023-07-31	48.83	29.00	Sell
2023-10-03	43.65	30.00	Sell
2023-11-03	43.36	32.00	Sell
2024-02-12	56.08	46.00	Sell
2024-03-25	55.33	45.00	Sell
2024-04-25	50.26	47.00	Sell
2024-07-08	57.78	50.00	Sell
2024-07-25	66.82	54.00	Sell
2024-10-07	66.60	60.00	Sell
2024-10-27	65.89	62.00	Sell

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.